Ascendiant Capital Markets Boosts Plus Therapeutics (NASDAQ:PSTV) Price Target to $20.50
Plus Therapeutics (NASDAQ:PSTV – Free Report) had its target price increased by Ascendiant Capital Markets from $20.00 to $20.50 in a research report released on Thursday morning,Benzinga reports. The firm currently has a buy rating on the stock. A number of other research analysts have also recently commented on PSTV. D Boral Capital cut Plus […]
Plus Therapeutics (NASDAQ:PSTV – Free Report) had its target price increased by Ascendiant Capital Markets from $20.00 to $20.50 in a research report released on Thursday morning,Benzinga reports. The firm currently has a buy rating on the stock. A number of other research analysts have also recently commented on PSTV. D Boral Capital cut Plus […]
